Previous evidence showed that CCAT2 knockout repressed endometrial cancer cell growth and invasion by binding to miR‐216b, and miR‐216b could negatively regulate Bcl‐2 that could active the mTOR pathway.38 Here, CCAT2 is linked to endometrial cancer.